
ALK-Abelló Investor Relations Material
Latest events

Q1 2025
ALK-Abelló
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ALK-Abelló
Access all reports
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company produces test kits for allergy and asthma assessment; allergy alert systems; blood pressure monitors; clinical chemistry analyzers; immunoassays and biochemistry instruments, Bruker X-ray fluorescence spectrometers, and various other products. It also provides allergy diagnostic solutions, including skin testing systems; test kits to identify urushiols that cause natural rubber allergies; laboratory equipment to measure patient serum samples suspected of having restricted proteins; a compact EDM device that helps dermatologists treat contact dermatitis via electromagnetic healing vibrations; a patch test panel to help prevent hospital patients from developing hypersensitivity and subsequent allergies during their stay; a test kit for the identification of contact urticaria triggered by nickel based alloys used in jewellery making and dental implants.
Key slides for ALK-Abelló


CMD 2024
ALK-Abelló


CMD 2024
ALK-Abelló
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
ALK
Country
🇩🇰 Denmark